ALMR: Q3 revenue up 68%, FY26 guidance raised on study wins
ALMR reported third-quarter revenue up 68% year on year and a 61.5% gross margin, lifting FY26 revenue guidance to $121M–$123M, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, ALMR's third-quarter revenue grew 68% year on year, while gross margin reached 61.5%. Consumables were the main driver of the growth.
The company credited wins in studies with UK Biobank and GSK for raising its outlook. It now expects FY26 revenue of $121M–$123M.
why it matters
Strong top-line growth and a high gross margin point to solid demand for the company's consumables. A raised guidance gives investors a firmer base for judging the stock's near-term outlook.
market impact
ALMR shares: strong revenue growth and higher guidance support interest in the stock
- ALMR shares pressure up — strong revenue growth and higher guidance support interest in the stock
tags
instruments
sources
- ALMR: Q3 revenue rose 68%; major study wins supported higher FY26 guidance — TradingView, 3 November 2026 at 23:09 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗